Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients
- 31 October 2008
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 69 (5), 804-811
- https://doi.org/10.1111/j.1365-2265.2008.03267.x
Abstract
Introduction Some hypothyroid patients continue to have significant impairments in psychological well-being, despite adequate treatment with levothyroxine (LT4). T4 transport across the blood-brain barrier is one of the crucial processes for thyroid hormone action in the brain. OATP1C1, a thyroid hormone transporter expressed at the blood-brain barrier, is considered to play a key role in delivering serum T4 to the brain. Objective To examine whether polymorphisms in OATP1C1 are determinants of well-being, neurocognitive functioning and preference for replacement therapy with a combination of LT4 and liothyronine (LT3). Design and participants We studied 141 patients with primary autoimmune hypothyroidism, adequately treated with LT4 monotherapy and participating in a randomized clinical trial comparing LT4 therapy with LT4-LT3 combination therapy. Outcome measurements Different questionnaires on well-being and neurocognitive tests were performed at baseline. Serum thyroid parameters, OATP1C1-intron3C > T, OATP1C1-Pro143Thr and OATP1C1-C3035T polymorphisms were determined. Results Allele frequencies of the OATP1C1 polymorphisms in patients with primary hypothyroidism were similar to those of healthy controls. Both the OATP1C1-intron3C > T and the OATP1C1-C3035T polymorphism, but not the OATP1C1-Pro143Thr polymorphism, were associated with symptoms of fatigue and depression. OATP1C1 polymorphisms were not associated with measures of neurocognitive functioning or preference for combined LT4-LT3 therapy. Conclusions OATP1C1 polymorphisms are associated with fatigue and depression, but do not explain differences in neurocognitive functioning or appreciation of LT4-LT3 combination therapy. Future studies are needed to confirm these findings.This publication has 29 references indexed in Scilit:
- Genotype-Phenotype Relationship in Patients with Mutations in Thyroid Hormone Transporter MCT8Endocrinology, 2008
- A second generation human haplotype map of over 3.1 million SNPsNature, 2007
- Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidismActa Endocrinologica, 2005
- Thyroid Hormone Transporters in Health and DiseaseThyroid®, 2005
- The International HapMap ProjectNature, 2003
- Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire studyClinical Endocrinology, 2002
- Deficits of Attention after Closed-Head Injury: Slowness Only?Journal of Clinical and Experimental Neuropsychology, 1996
- Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.JCI Insight, 1995
- The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueJournal of Psychosomatic Research, 1995
- Information processing in depression and anxietyPsychological Medicine, 1987